Chinese Journal of Pharmaceuticals
|
2024, 55(1): 137-142
• Pharmaceutical Management & Information •
Research on the Current Production Situation and Institutional Innovation of Cross-border Drug Holding under the MAH System
Full
Jinlian LI
1, Yifan YANG
1, Jinping XIE
1, Yun WANG
2, Rong SHAO
1, *
Affiliations
- 1.NMPA Key Lab. for Drug Regulatory Innovation and Evaluation, Institute of Regulatory Science, China Pharmaceutical University, Nanjing 211198
- 2.China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee, Beijing 100004
Published: 2024-01-10
doi: 10.16522/j.cnki.cjph.2024.01.019
Outline
李锦连, 杨伊凡, 谢金平, 王芸, 邵蓉.
MAH制度下药品跨境持有与生产管理现状及制度创新研究.
中国医药工业杂志,
2024
, 55
(1)
: 137
-142
.
DOI: 10.16522/j.cnki.cjph.2024.01.019
Jinlian LI, Yifan YANG, Jinping XIE, Yun WANG, Rong SHAO.
Research on the Current Production Situation and Institutional Innovation of Cross-border Drug Holding under the MAH System[J].
Chinese Journal of Pharmaceuticals,
2024
, 55
(1)
: 137
-142
.
DOI: 10.16522/j.cnki.cjph.2024.01.019
Year 2024 volume 55 Issue 1
28
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.01.019
- Receive Date:2023-05-19
- Online Date:2026-11-19
- Published:2024-01-10